[1] 翁子骞,朱月,胡思宁,等.泛血管动脉粥样硬化性疾病的研究进展[J].心血管病学进展,2023,44(12):1094-1097. WENG Z Q,ZHU Y,HU S N,et al.Panvascular atherosclerotic disease[J].Adv Cardiovasc Dis,2023,44(12):1094-1097. [2] 杨靖,张英梅,葛均波.泛血管疾病防控——从疾病治疗到综合管理[J].中华心血管病杂志(网络版),2021,4(1):1-6. YANG J,ZHANG Y M,GE J B.Prevention and control of pan-vascular diseases:from disease treatment to comprehensive management[J].Chin J Cardiol Online Ed,2021,4(1):1-6. [3] ZHU B.Molecular mechanisms underlying atherosclerosis and current advances in targeted therapeutics[J].Int J Mol Sci,2026,27(2):634. [4] 徐索文,葛均波,翁建平.内皮功能失调与泛血管疾病[J].中国科学技术大学学报,2021,51(8):577-585. XU S W,GE J B,WENG J P.Endothelial dysfunction and panvascular diseases[J].J Univ Sci Technol China,2021,51(8):577-585. [5] TIAN Y,ZONG Y,PANG Y,et al.Platelets and diseases:Signal transduction and advances in targeted therapy[J].Sig Transduct Target Ther,2025,10(1):159. [6] BROWN G T,MCINTYRE T M.Lipopolysaccharide signaling without a nucleus:Kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles[J].J Immunol,2011,186(9):5489-5496. [7] WONG M,DAI Y,GE J.Pan-vascular disease:What we have done in the past and what we can do in the future?[J].Cardiol Plus,2024,9(1):1-5. [8] 国家心血管病中心.中国心血管健康与疾病报告-2021[M].北京:科学出版社,2022. China National Center for Cardiovascular Diseases.Annual report on cardiovascular health and disease in China(2021)[M].Beijing:Science Press,China,2022. [9] HOTTZ E D,AZEVEDO-QUINTANILHA I G,PALHIN-HA L,et al.Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19[J].Blood,2020,136(11):1330-1341. [10] BARRETT T J,SCHLEGEL M,ZHOU F,et al.Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis[J].Sci Transl Med,2019,11(517):eaax0481. [11] BARREIRO O,ZAMAI M,YÁÑEZ-MÓ M,et al.Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms[J].J Cell Biol,2008,183(3):527-542. [12] LAFFONT B,CORDUAN A,ROUSSEAU M,et al.Platelet microparticles reprogram macrophage gene expression and function[J].Thromb Haemost,2016,115(2):311-323. [13] PANENI F,BECKMAN J A,CREAGER M A,et al.Diabetes and vascular disease:pathophysiology,clinical consequences,and medical therapy:part I[J].Eur Heart J,2013,34(31):2436-2443. [14] SAKURAI K,SAWAMURA T.Stress and vascular responses:Endothelial dysfunctionvialectin-like oxidized low-density lipoprotein receptor-1:Close relationships with oxidative stress[J].J Pharmacol Sci,2003,91(3):182-186. [15] ZHOU R,TARDIVEL A,THORENS B,et al.Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J].Nat Immunol,2010,11(2):136-140. [16] STARK K,PHILIPPI V,STOCKHAUSEN S,et al.Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice[J].Blood,2016,128(20):2435-2449. [17] HIEBERT P R,BOIVIN W A,ZHAO H,et al.Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice[J].PLoS One,2013,8(10):e78939. [18] EDSFELDT A,DUNÉR P,STÅHLMAN M,et al.Sphingolipids contribute to human atherosclerotic plaque inflammation[J].Arterioscler Thromb Vasc Biol,2016,36(6):1132-1140. [19] DE LOS SANTOS C,CHANG C W,MYCEK M A,et al.FRAP,FLIM,and FRET:Detection and analysis of cellular dynamics on a molecular scale using fluorescence microscopy[J].Mol Reprod Dev,2015,82(7-8):587-604. [20] MEKURIA T A,KINDE M Z.Basic principles and applications of live cell microscopy techniques:A review[J].World’s Vet J,2022:339-346. [21] WEISS J N,KORGE P,HONDA H M,et al.Role of the mitochondrial permeability transition in myocardial disease[J].Circ Res,2003,93(4):292-301. [22] BOCK F J,TAIT S W G.Mitochondria as multifaceted regulators of cell death[J].Nat Rev Mol Cell Biol,2020,21(2):85-100. |